Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Sugars × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 15 Genitourinary 8 Thoracic 4 Plasma cell 4 Lymphoid 4 Head & Neck 4 Other 3 Gynecologic 3 Gastrointestinal 3 Other hematologic neoplasm 2 Dermatologic 2 Tumor-Agnostic 1 Sarcoma 1 Other solid neoplasm 1 Other neoplasm 1 Myeloid 1 Classical hematology 1 CNS 1

Conditions

Interventions

Cyclophosphamide 195 Radiotherapy 191 Doxorubicin 185 Temozolomide 166 Ifosfamide 108 Filgrastim 99 Imatinib Mesylate 90 Etoposide 90 Vincristine 83 Gemcitabine 76 Bevacizumab 74 Irinotecan 73 Magnetic Resonance Spectroscopy 69 pembrolizumab 64 Radiation 60 Carboplatin 58 pazopanib 54 Methotrexate 53 Cisplatin 51 fludarabine phosphate 50 Nivolumab 50 Specimen Handling 49 Peripheral Blood Stem Cell Transplantation 45 Trabectedin 44 Docetaxel 44 Biopsy 44 Melphalan 42 Busulfan 42 Paclitaxel 39 fludarabine 38

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02606461 2023-01-23

SEAL

Karyopharm Therapeutics Inc

Phase 2/3 Completed

342 enrolled 36 charts

Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡